The purpose of this study is to evaluate the safety, efficacy, and duration of effect of a single administration of Anecortave Acetate Depot for treatment of elevated intraocular pressure (IOP) in patients with open-angle glaucoma.

Inclusion Criteria:

• Patients 18 years of age or older with open-angle glaucoma.
• Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

• Patients with open-angle glaucoma with a pseudoexfoliation or pigment dispersion component.
• Other protocol-defined exclusion criteria may apply.